Health
-
J&J’s two-drug combo blocked tumors in advanced multiple myeloma
ASH 2025 had both rain and sun, positive and negative data in Orlando, Fla. ASH 2025 was in Orlando, Fla.…
Read More » -
WHO issues guidance on GLP-1 drugs for obesity, calls them a “scientific breakthrough” and “new chapter”
The World Health Organization (WHO) has released new guidelines recommending the use of GLP-1 drugs for the treatment of obesity.…
Read More » -
Here’s How Much Medline’s Founding Family Is Worth, Per Pending IPO
The Mills family, known for their founding of the medical supplies giant Medline, made headlines in 2021 when they cashed…
Read More » -
At ASH, positive news for Terns, Kura leukemia treatments
The American Society of Hematology (ASH) meeting is a significant event in the world of medicine, where groundbreaking research and…
Read More » -
Feds promised “radical transparency” but are withholding rural health fund applications
State leaders have unveiled innovative ideas for utilizing their portion of a $50 billion federal rural health program, including medication-delivering…
Read More » -
NIH Awarded 22% Fewer Grants In 2025, A 24% Drop In Cancer Research
The National Institutes of Health (NIH) has seen a significant decrease in the number of grants awarded this year under…
Read More » -
A promising sickle cell pill and a new way to treat myelofibrosis
The American Society of Hematology (ASH) meeting is in full swing, and exciting news is already emerging. One of the…
Read More » -
Appointment of controversial FDA official rocking agency like “an atom bomb,” scientists there say
The recent appointment of Dr. Tracy Beth Høeg as acting director of the FDA’s Center for Drug Evaluation and Research…
Read More » -
Fulcrum sickle cell pill data at ASH: Higher dose works better
Fulcrum Therapeutics announced on Sunday that a higher dosage of its experimental medication for sickle cell disease showed promising results…
Read More » -
7 deaths, hundreds of injuries may be linked to diabetes glucose monitor errors, FDA says
Patients are being urged to discontinue the use of certain glucose monitors manufactured by Abbott Diabetes Care following the discovery…
Read More »